Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 2, 2014New England Journal of Medicine

Giant-Cell Arteritis and Polymyalgia Rheumatica

View Full Paper
Ask AI
Bookmark
Share

Authors

Cornelia M. Weyand
Cornelia M. WeyandMayo Clinic
Jörg J. Goronzy
Jörg J. GoronzyVascular / Pulmonary Vascular

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Weyand et al. (2014) studied this question.

synapsesocial.com/papers/6a75c4e9650b5ffb848b82cfhttps://doi.org/10.1056/nejmcp1214825
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1INTERLEUKIN-6 IN SERUM OF PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS1990 · 177 citations
  2. 2Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.2007 · 198 citations
  3. 3BSR and BHPR guidelines for the management of polymyalgia rheumatica2009 · 252 citations
  4. 4Rapid induction of remission in large vessel vasculitis by IL-6 blockade2011 · 190 citations
  5. 5Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.2007 · 564 citations